Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 0615-8239

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 0615-8239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sevelmer Carbonate Tabs 800mg 1)

Chemical structure diagram of Sevelamer Carbonate showing polymeric units with primary amine groups, crosslinking groups, and bicarbonate ions, illustrating the extended polymer network typical of this compound.*

FDA Label Image

Figure 3 (Sevelmer Carbonate Tabs 800mg 2)

A line graph depicting the percentage of patients attaining a reduction in serum phosphorus at least as great as the value on the X-axis. The X-axis represents reduction in serum phosphorus (mg/dL) from -4 to 8, with negative values indicating worsening increase and positive values indicating improved reduction. The Y-axis shows the percentage of patients from 0 to 100%. Two curves are displayed: one for Sevelamer Hydrochloride and one for an Active Control, showing comparative patient responses.*

FDA Label Image

Figure 4 (Sevelmer Carbonate Tabs 800mg 3)

A line graph titled 'Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment' comparing phosphorus level changes over 52 weeks between Sevelamer Hydrochloride treatment and an Active-Control. The y-axis shows phosphorus change from baseline, ranging from -5 to 2, and the x-axis represents the study week from 0 to 52. Two lines chart phosphorus levels over time for each group.*

FDA Label Image

Principal Display Panel (Sevelamer Carbonate Tabs 800mg)

Sevelamer Carbonate 800 mg film-coated oral tablets packaging label featuring lot number, expiration date, and quantity of 30 tablets. The label indicates the product is Rx only and is manufactured by Aurobindo with packaging by Vanguard Labs in Glasgow, KY. The label includes storage instructions to store at controlled room temperature and to protect from moisture, along with multiple barcode representations and a message for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.